Cargando…

Estimation of magnesium in patients with functional hypoparathyroidism

CONTEXT: It is evident that about 30-50% of patients with Vitamin D deficiency (VDD) do not manifest develop secondary hyperparathyroidism (SHPT). A number of theories have been proposed to explain this lack of SHPT, including hypomagnesemia. SETTINGS AND DESIGN: Retrospective review of laboratory d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kannan, Subramanian, Mahadevan, Shriraam, Velayutham, P., Bharath, R., Kumaravel, V., Muthukumaran, J., Premkumar, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192988/
https://www.ncbi.nlm.nih.gov/pubmed/25364677
http://dx.doi.org/10.4103/2230-8210.141365
_version_ 1782338886064668672
author Kannan, Subramanian
Mahadevan, Shriraam
Velayutham, P.
Bharath, R.
Kumaravel, V.
Muthukumaran, J.
Premkumar, A.
author_facet Kannan, Subramanian
Mahadevan, Shriraam
Velayutham, P.
Bharath, R.
Kumaravel, V.
Muthukumaran, J.
Premkumar, A.
author_sort Kannan, Subramanian
collection PubMed
description CONTEXT: It is evident that about 30-50% of patients with Vitamin D deficiency (VDD) do not manifest develop secondary hyperparathyroidism (SHPT). A number of theories have been proposed to explain this lack of SHPT, including hypomagnesemia. SETTINGS AND DESIGN: Retrospective review of laboratory database. MATERIALS AND METHODS: We evaluated the differences in serum magnesium (Mg) levels among those with VDD with or without SHPT. A retrospective review of 6255 laboratory data of bone mineral profiles performed in the period of 2007–2013. After excluding patients with hypercalcemia, renal dysfunction/unknown kidney function and primary hypothyroidism, the remaining 1323 patient data were analyzed. SHPT was defined as serum parathyroid hormone >65 in those with VDD. STATISTICAL ANALYSIS USED: ANOVA and Wilcoxon tests as appropriate to compare means. Multivariate logistic regression to analyze relation between variables and outcome of SHPT. RESULTS: We noted that 55% patients (n = 727) had VDD, and among those who had VDD, 23% (n = 170) were hypocalcemic (corrected serum calcium <8.5). Patients with VDD who did not exhibit SHPT were 56% (n = 407). The mean (±standard deviation) serum Mg levels in the entire cohort (n = 1323) was 1.94 ± 0.26 mg/dl and 1.95 ± 0.26 mg/dl in VDD cohort and 2 ± 0.31 mg/dl in the VDD-hypocalcemic cohort. There was no statistical difference in the Mg levels among those with SHPT compared to those without SHPT (P = 0.14). Serum calcium and phosphorus were lower in those with SHPT (P = 0.06 and P < 0.001, respectively). In multivariate logistic regression, serum calcium (P = 0.043), phosphorus (P < 0.001) and severe VDD (P < 0.001) independently correlated with occurrence of SHPT in VDD. CONCLUSIONS: Serum Mg levels did not explain the functional hypoparathyroidism seen in about half of the patients with VDD. A low normal serum calcium and phosphorus levels are more likely to be associated with VDD patients who develop SHPT.
format Online
Article
Text
id pubmed-4192988
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41929882014-11-01 Estimation of magnesium in patients with functional hypoparathyroidism Kannan, Subramanian Mahadevan, Shriraam Velayutham, P. Bharath, R. Kumaravel, V. Muthukumaran, J. Premkumar, A. Indian J Endocrinol Metab Original Article CONTEXT: It is evident that about 30-50% of patients with Vitamin D deficiency (VDD) do not manifest develop secondary hyperparathyroidism (SHPT). A number of theories have been proposed to explain this lack of SHPT, including hypomagnesemia. SETTINGS AND DESIGN: Retrospective review of laboratory database. MATERIALS AND METHODS: We evaluated the differences in serum magnesium (Mg) levels among those with VDD with or without SHPT. A retrospective review of 6255 laboratory data of bone mineral profiles performed in the period of 2007–2013. After excluding patients with hypercalcemia, renal dysfunction/unknown kidney function and primary hypothyroidism, the remaining 1323 patient data were analyzed. SHPT was defined as serum parathyroid hormone >65 in those with VDD. STATISTICAL ANALYSIS USED: ANOVA and Wilcoxon tests as appropriate to compare means. Multivariate logistic regression to analyze relation between variables and outcome of SHPT. RESULTS: We noted that 55% patients (n = 727) had VDD, and among those who had VDD, 23% (n = 170) were hypocalcemic (corrected serum calcium <8.5). Patients with VDD who did not exhibit SHPT were 56% (n = 407). The mean (±standard deviation) serum Mg levels in the entire cohort (n = 1323) was 1.94 ± 0.26 mg/dl and 1.95 ± 0.26 mg/dl in VDD cohort and 2 ± 0.31 mg/dl in the VDD-hypocalcemic cohort. There was no statistical difference in the Mg levels among those with SHPT compared to those without SHPT (P = 0.14). Serum calcium and phosphorus were lower in those with SHPT (P = 0.06 and P < 0.001, respectively). In multivariate logistic regression, serum calcium (P = 0.043), phosphorus (P < 0.001) and severe VDD (P < 0.001) independently correlated with occurrence of SHPT in VDD. CONCLUSIONS: Serum Mg levels did not explain the functional hypoparathyroidism seen in about half of the patients with VDD. A low normal serum calcium and phosphorus levels are more likely to be associated with VDD patients who develop SHPT. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4192988/ /pubmed/25364677 http://dx.doi.org/10.4103/2230-8210.141365 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kannan, Subramanian
Mahadevan, Shriraam
Velayutham, P.
Bharath, R.
Kumaravel, V.
Muthukumaran, J.
Premkumar, A.
Estimation of magnesium in patients with functional hypoparathyroidism
title Estimation of magnesium in patients with functional hypoparathyroidism
title_full Estimation of magnesium in patients with functional hypoparathyroidism
title_fullStr Estimation of magnesium in patients with functional hypoparathyroidism
title_full_unstemmed Estimation of magnesium in patients with functional hypoparathyroidism
title_short Estimation of magnesium in patients with functional hypoparathyroidism
title_sort estimation of magnesium in patients with functional hypoparathyroidism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192988/
https://www.ncbi.nlm.nih.gov/pubmed/25364677
http://dx.doi.org/10.4103/2230-8210.141365
work_keys_str_mv AT kannansubramanian estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism
AT mahadevanshriraam estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism
AT velayuthamp estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism
AT bharathr estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism
AT kumaravelv estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism
AT muthukumaranj estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism
AT premkumara estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism